Skip to main content
. 2020 May 26;11(21):1942–1952. doi: 10.18632/oncotarget.27600

Figure 2. Depicted are representative images of subjects treated on PNOC-002 demonstrating.

Figure 2

(A) regression of a contrast enhancing cystic lesion on a contrast, T1 weighted MR image over time; (B) regression of a solid/cystic lesion on a T2 weighted MR image over time; (C) regression of a contrast enhancing solid lesion on a contrast, T1 weighted MR image over time.